Search research articles
Contact Us
Filters
Showing results (241-250 of 261) with videos related to
Page
of 27
Sort By:
World Journal of Gastroenterology
|
August 28, 2024
Hepatic angiotensin-converting enzyme 2 expression in metabolic dysfunction-associated steatotic liver disease and in patients with fatal COVID-19
Angus K Jacobs, Steven D Morley, Kay Samuel, et al.
Journal of Clinical Medicine
|
June 28, 2023
Metabolism of Acetaminophen by Enteric Epithelial Cells Mitigates Hepatocellular Toxicity In Vitro
Katie Morgan, Steven D Morley, Arslan K Raja, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 21, 2009
Design of selective Cathepsin inhibitors
Paul A Bethel, Stefan Gerhardt, Emma V Jones, et al.
The Review of Scientific Instruments
|
November 4, 2011
Magnifying lens for 800 MeV proton radiography
F E Merrill, E Campos, C Espinoza, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 24, 2009
5-Aminopyrimidin-2-ylnitriles as cathepsin K inhibitors
Andrew D Morley, Peter W Kenny, Brenda Burton, et al.
Translational Oncology
|
August 3, 2019
DIVERSet JAG Compounds Inhibit Topoisomerase II and Are Effective Against Adult and Pediatric High-Grade Gliomas
Alison Howarth, Claire Simms, Nitesh Kerai, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)
|
May 26, 2001
Complications common to ventricular assist device support are rare with 90 days of DeBakey VAD support in calves
T W Fossum, D Morley, D B Olsen, et al.
Lipids in Health and Disease
|
August 3, 2016
Erratum to: Fibrinogen production is enhanced in an in-vitro model of non-alcoholic fatty liver disease: an isolated risk factor for cardiovascular events?
Emily N W Yeung, Philipp Treskes, Sarah F Martin, et al.
Lipids in Health and Disease
|
August 11, 2015
Fibrinogen production is enhanced in an in-vitro model of non-alcoholic fatty liver disease: an isolated risk factor for cardiovascular events?
Emily N W Yeung, Philipp Treskes, Sarah F Martin, et al.
Drug Discovery Today
|
August 3, 2013
Fragment-based hit identification: thinking in 3D
Andrew D Morley, Angelo Pugliese, Kristian Birchall, et al.
Page
of 27
Search research articles
Search
Showing results (241-250 of 261) with videos related to
Sort By:
Page
of 27
World Journal of Gastroenterology
|
August 28, 2024
Hepatic angiotensin-converting enzyme 2 expression in metabolic dysfunction-associated steatotic liver disease and in patients with fatal COVID-19
Angus K Jacobs, Steven D Morley, Kay Samuel, et al.
Journal of Clinical Medicine
|
June 28, 2023
Metabolism of Acetaminophen by Enteric Epithelial Cells Mitigates Hepatocellular Toxicity In Vitro
Katie Morgan, Steven D Morley, Arslan K Raja, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 21, 2009
Design of selective Cathepsin inhibitors
Paul A Bethel, Stefan Gerhardt, Emma V Jones, et al.
The Review of Scientific Instruments
|
November 4, 2011
Magnifying lens for 800 MeV proton radiography
F E Merrill, E Campos, C Espinoza, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 24, 2009
5-Aminopyrimidin-2-ylnitriles as cathepsin K inhibitors
Andrew D Morley, Peter W Kenny, Brenda Burton, et al.
Translational Oncology
|
August 3, 2019
DIVERSet JAG Compounds Inhibit Topoisomerase II and Are Effective Against Adult and Pediatric High-Grade Gliomas
Alison Howarth, Claire Simms, Nitesh Kerai, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)
|
May 26, 2001
Complications common to ventricular assist device support are rare with 90 days of DeBakey VAD support in calves
T W Fossum, D Morley, D B Olsen, et al.
Lipids in Health and Disease
|
August 3, 2016
Erratum to: Fibrinogen production is enhanced in an in-vitro model of non-alcoholic fatty liver disease: an isolated risk factor for cardiovascular events?
Emily N W Yeung, Philipp Treskes, Sarah F Martin, et al.
Lipids in Health and Disease
|
August 11, 2015
Fibrinogen production is enhanced in an in-vitro model of non-alcoholic fatty liver disease: an isolated risk factor for cardiovascular events?
Emily N W Yeung, Philipp Treskes, Sarah F Martin, et al.
Drug Discovery Today
|
August 3, 2013
Fragment-based hit identification: thinking in 3D
Andrew D Morley, Angelo Pugliese, Kristian Birchall, et al.
Page
of 27